Cardiology VIVA:
ECG MASTER LIST (70 Systematic Approach)
When the examiner puts that trace in front of you, don't just name the pattern—systematize your verbal response to demonstrate clinical maturity.
Here is the master checklist to ensure you never miss a mark on these 70 essentials:
THE DISTINCTION SYSTEMATIC APPROACH
For every ECG spotter, your verbal response must follow this sequence:
Rate & Rhythm: Establish if it is regular/irregular and atrial/ventricular driven.
Axis: Calculate the QRS axis (especially critical for fascicular blocks and RVH/LVH).
Intervals: Measure PR, QRS, and QTc (mandatory for WPW, CHB, and Long QT).
Morphology: Point to the specific "pathognomonic sign" (e.g., "Note the delta wave in V4-V6" for WPW).
Clinical Integration: Always finish with a clinical pearl (e.g., "In this Brugada pattern, I would specifically ask for a family history of sudden cardiac death").
SYSTEMATIC VIVA ECG MASTER LIST
1. LBBB
Diagnosis: Left Bundle Branch Block.
Pathognomonic Sign: QRS > 120ms, broad notched R-waves in I, aVL, V5, V6, and loss of septal Q-waves.
Clinical Risk: Masking of underlying myocardial infarction.
Management: Apply Modified Sgarbossa criteria to evaluate for active ischemia.
Cross-Examination (5 Q&A):
Q: How do you differentiate new vs. old LBBB? A: Compare with previous ECGs; new LBBB with chest pain is an ACS equivalent.
Q: What is the Sgarbossa criterion for discordant ST elevation? A: > 1mm discordance in a lead with a positive QRS.
Q: Does LBBB preclude PCI? A: No, it mandates urgent activation.
Q: Can LBBB cause heart failure? A: Yes, through mechanical dyssynchrony.
Q: When is CRT indicated? A: LVEF ≤ 35% and QRS ≥ 150ms.
2. RBBB
Diagnosis: Right Bundle Branch Block.
Pathognomonic Sign: rSR' pattern in V1 and wide slurred S-wave in lead I.
Clinical Risk: Associated structural heart disease (e.g., ASD).
Management: Echocardiography to rule out right-sided volume overload.
Cross-Examination (5 Q&A):
Q: Is RBBB always pathological? A: Often benign, but requires investigation if new.
Q: What heart defect is classically associated? A: Atrial Septal Defect (ASD).
Q: Can RBBB hide a STEMI? A: Less than LBBB, but still obscures ST segments.
Q: What if RBBB is combined with axis deviation? A: Indicates bifascicular block.
Q: Does it require a pacemaker? A: Only if associated with symptomatic AV block.
3. LAFB/LPFB
Diagnosis: Left Anterior/Posterior Fascicular Block.
Pathognomonic Sign: LAFB: LAD (-45° to -90°) with qR in I/aVL; LPFB: RAD (>+90°) with qR in II/III/aVF.
Clinical Risk: Progression to bifascicular block.
Management: Review previous ECGs; clinical correlation.
Cross-Examination (5 Q&A):
Q: Which is more common? A: LAFB.
Q: Does LAFB require pacing? A: No, usually isolated.
Q: What is LPFB often associated with? A: CAD.
Q: How do you check for progression? A: Serial ECGs and Holter.
Q: Does it affect QRS duration? A: Minimal widening, if any.
4. Bifascicular Block
Diagnosis: Bifascicular Block (RBBB + LAFB).
Pathognomonic Sign: RBBB morphology in V1 + LAD with qR in I/aVL.
Clinical Risk: High-grade AV block.
Management: Holter monitoring to check for transient AV block.
Cross-Examination (5 Q&A):
Q: What is the third fascicle? A: Left posterior fascicle.
Q: Is an EPS indicated? A: If syncope is present.
Q: What is the risk of sudden death? A: Low if asymptomatic.
Q: Can you perform surgery? A: Yes, with caution.
Q: What if the patient has syncope? A: Likely needs a pacemaker.
5. WPW Syndrome
Diagnosis: Wolff-Parkinson-White syndrome.
Pathognomonic Sign: Short PR (<120ms) and Delta wave.
Clinical Risk: Sudden death during rapid AFib.
Management: EPS and Radiofrequency Ablation.
Cross-Examination (5 Q&A):
Q: Why avoid AV nodal blockers in AFib? A: They facilitate accessory pathway conduction.
Q: What is the most dangerous rhythm? A: AFib with rapid ventricular response.
Q: Which drug is safe in AFib? A: Procainamide.
Q: What defines a "high risk" accessory pathway? A: Short refractory period.
Q: What is the delta wave? A: Early ventricular activation.
6. Atrial Fibrillation
Diagnosis: Atrial Fibrillation.
Pathognomonic Sign: Irregularly irregular rhythm with absent P-waves.
Clinical Risk: Stroke/systemic embolism.
Management: Anticoagulation (CHA2DS2-VASc score) and rate/rhythm control.
Cross-Examination (5 Q&A):
Q: Define lone AF? A: AF without structural heart disease.
Q: What is the window for cardioversion? A: < 48 hours.
Q: Can you cardiovert after 48h? A: Only with TEE or 3 weeks anticoagulation.
Q: What is the rate control target? A: < 110 bpm.
Q: What is the most common site of origin? A: Pulmonary veins.
7. Atrial Flutter
Diagnosis: Typical Atrial Flutter.
Pathognomonic Sign: Sawtooth flutter waves (II, III, aVF) at 250–300 bpm.
Clinical Risk: High-grade AV block/stroke.
Management: Cavo-tricuspid isthmus (CTI) ablation.
Cross-Examination (5 Q&A):
Q: What is "Typical"? A: Counter-clockwise CTI-dependent.
Q: What is "Reverse Typical"? A: Clockwise CTI-dependent.
Q: Why is 2:1 block common? A: AV node refractory period.
Q: Can it transition to AF? A: Yes.
Q: Is anticoagulation needed? A: Yes, same as AF.
8. Complete Heart Block (CHB)
Diagnosis: Third-Degree AV Block.
Pathognomonic Sign: Complete AV dissociation; P-waves and QRS independent.
Clinical Risk: Asystole/syncope.
Management: Urgent temporary transvenous pacing + Permanent Pacemaker (PPM).
Cross-Examination (5 Q&A):
Q: What is the escape rhythm? A: Junctional (narrow) or ventricular (wide).
Q: Is atropine useful? A: Rarely in distal blocks.
Q: Causes in young people? A: Congenital/myocarditis.
Q: What is the risk of asystole? A: High in distal block.
Q: Emergency treatment? A: Transcutaneous/transvenous pacing.
9. Mobitz II
Diagnosis: Second-Degree AV Block, Mobitz II.
Pathognomonic Sign: Fixed PR interval with unpredictable dropped beats.
Clinical Risk: Sudden progression to CHB.
Management: Immediate PPM implantation.
Cross-Examination (5 Q&A):
Q: Why is it dangerous? A: Usually infra-Hisian.
Q: Can you give beta-blockers? A: No.
Q: Difference from Mobitz I? A: Mobitz I has PR lengthening.
Q: What is the site? A: His-Purkinje.
Q: Prognosis? A: Poor without pacing.
10. STEMI (Anterior)
Diagnosis: Anterior Wall MI.
Pathognomonic Sign: ST elevation V1–V4.
Clinical Risk: Cardiogenic shock/LAD occlusion.
Management: Primary PCI (door-to-balloon < 90m).
Cross-Examination (5 Q&A):
Q: What vessel? A: LAD.
Q: Complication? A: VSD.
Q: Reciprocal changes? A: II, III, aVF.
Q: What if PCI is unavailable? A: Thrombolytics (<30m).
Q: Loading dose? A: Aspirin/Ticagrelor.
11. STEMI (Inferior)
Diagnosis: Inferior Wall MI.
Pathognomonic Sign: ST elevation II, III, aVF.
Clinical Risk: RV infarction.
Management: Right-sided leads (V3R-V4R); avoid nitrates if RV infarction is confirmed.
Cross-Examination (5 Q&A):
Q: Vessel? A: RCA.
Q: What is Kounis syndrome? A: Allergy-induced MI.
Q: Why avoid nitrates? A: Preload dependence of RV.
Q: What is the "Mirror image"? A: ST depression in I, aVL.
Q: Bradycardia in Inferior MI? A: RCA ischemia to AV node.
12. STEMI (Posterior)
Diagnosis: Posterior Wall MI.
Pathognomonic Sign: ST depression and tall R-waves in V1–V3.
Clinical Risk: Large infarct size; often missed.
Management: Place posterior leads (V7–V9) to confirm ST elevation; urgent PCI.
Cross-Examination (5 Q&A):
Q: Why is it missed? A: Standard leads don't see the back.
Q: Which vessel? A: LCx or RCA.
Q: Reciprocal leads? A: V1-V3.
Q: Treatment? A: Same as STEMI.
Q: Mortality? A: High if undiagnosed.
13. Pericarditis
Diagnosis: Acute Pericarditis.
Pathognomonic Sign: Diffuse ST elevation and PR segment depression.
Clinical Risk: Cardiac tamponade.
Management: NSAIDs and Colchicine.
Cross-Examination (5 Q&A):
Q: Diff vs MI? A: PR depression.
Q: Specific sign? A: Spodick sign.
Q: When to give steroids? A: Refractory cases.
Q: Tamponade signs? A: Pulsus paradoxus.
Q: ECG evolution? A: 4 stages.
14. Hyperkalemia
Diagnosis: Severe Hyperkalemia.
Pathognomonic Sign: Tall, peaked T-waves; loss of P; widened QRS.
Clinical Risk: Ventricular asystole/VF.
Management: IV Calcium Gluconate (stabilizer) + Insulin/Dextrose.
Cross-Examination (5 Q&A):
Q: First sign? A: Peaked T.
Q: What does Calcium do? A: Stabilizes membrane.
Q: How to shift K+? A: Insulin + Dextrose.
Q: How to remove K+? A: Kayexalate/Dialysis.
Q: Can it mimic MI? A: Yes, pseudoinfarction.
15. Hypokalemia
Diagnosis: Hypokalemia.
Pathognomonic Sign: U-waves (post-T wave deflection).
Clinical Risk: Ventricular arrhythmias (Torsades).
Management: K+ repletion; monitor for QT prolongation.
Cross-Examination (5 Q&A):
Q: Why U-waves? A: Delayed Purkinje repolarization.
Q: Arrhythmia? A: Torsades.
Q: Common cause? A: Diuretics.
Q: K+ target? A: > 4.0 mEq/L.
Q: Digoxin interaction? A: Increases toxicity.
16. Digitalis Toxicity
Diagnosis: Digitalis toxicity.
Pathognomonic Sign: Down-sloping "Salvador Dali" ST depression.
Clinical Risk: Bidirectional VT or high-grade AV block.
Management: Hold Digoxin, check K+, use Fab fragments if severe.
Cross-Examination (5 Q&A):
Q: Mechanism? A: Na+/K+ ATPase inhibition.
Q: What is bidirectional VT? A: Alternating QRS axis.
Q: Electrolyte risk? A: Hypokalemia.
Q: Does it slow HR? A: Yes, vagal effect.
Q: When to use Fab? A: Arrhythmias/Shock.
17. LVH
Diagnosis: Left Ventricular Hypertrophy.
Pathognomonic Sign: Sokolow-Lyon (S in V1+R in V5 > 35mm).
Clinical Risk: HF, arrhythmias, and sudden death.
Management: Echocardiography to assess wall thickness.
Cross-Examination (5 Q&A):
Q: Cornell criteria? A: RaVL+SV3 > 28mm.
Q: Strain pattern? A: ST depression/T-wave inversion.
Q: Causes? A: HTN, AS.
Q: Sensitivity? A: Low.
Q: Does it regress? A: Yes, with BP control.
18. RVH
Diagnosis: Right Ventricular Hypertrophy.
Pathognomonic Sign: R/S > 1 in V1, RAD.
Clinical Risk: Severe pulmonary hypertension.
Management: Echocardiography to measure PASP.
Cross-Examination (5 Q&A):
Q: Strain pattern? A: ST depression V1-V3.
Q: Causes? A: COPD, MS.
Q: In children? A: Normal (R in V1).
Q: What is the "S1S2S3" pattern? A: Severe RVH.
Q: Clinical sign? A: Parasternal heave.
19. Long QT Syndrome
Diagnosis: Long QT Syndrome.
Pathognomonic Sign: QTc > 470ms (m) or 480ms (f).
Clinical Risk: Torsades de Pointes.
Management: Beta-blockers, avoid QT-prolonging drugs.
Cross-Examination (5 Q&A):
Q: Bazett’s formula? A: QT / sqrt(RR).
Q: First line? A: Beta-blockers.
Q: Triggers? A: Emotion/Exercise.
Q: Genetic? A: KCNQ1, HERG.
Q: Acquired causes? A: Drugs/Electrolytes.
20. Brugada Syndrome
Diagnosis: Brugada Type 1 Pattern.
Pathognomonic Sign: Coved ST elevation V1–V2.
Clinical Risk: Polymorphic VT and sudden death.
Management: ICD evaluation; avoid triggers (fever/drugs).
Cross-Examination (5 Q&A):
Q: Triggers? A: Fever, vagal, drugs.
Q: Type 2 vs Type 1? A: Saddleback vs Coved.
Q: Diagnosis? A: Spontaneous or Provoked.
Q: Inheritance? A: AD.
Q: Why ICD? A: Only proven prevention for SD.
20 ESSENTIAL CHD ECG PATTERNS
1. ASD (Ostium Secundum)
Diagnosis: Secundum ASD. Pathognomonic Sign: RBBB with RAD (or normal axis) and "rsr'" pattern in V1. Clinical Risk: PHTN, Atrial arrhythmias. Management: Echo for shunt assessment (Qp:Qs).
Cross-Exam: 1. Q: Why RBBB? A: RV volume overload. 2. Q: Why RAD? A: ASD Primum causes LAD, Secundum is normal/RAD. 3. Q: Can it cause AF? A: Yes, later in life. 4. Q: What is Lutembacher syndrome? A: ASD + MS. 5. Q: When to close? A: Qp:Qs > 1.5.
2. ASD (Ostium Primum)
Diagnosis: Primum ASD. Pathognomonic Sign: RBBB with Left Axis Deviation (LAD) and prolonged PR interval. Clinical Risk: Mitral regurgitation. Management: Echo to assess mitral valve cleft.
Cross-Exam: 1. Q: Why LAD? A: AV canal defect involvement. 2. Q: Difference from Secundum? A: Axis deviation. 3. Q: Which valve is affected? A: Mitral. 4. Q: Is it endocardial cushion defect? A: Yes. 5. Q: Surgery urgency? A: Higher due to MR.
3. Tetralogy of Fallot (ToF)
Diagnosis: ToF. Pathognomonic Sign: Right Axis Deviation (RAD) and prominent RVH in V1 (R wave). Clinical Risk: Sudden cardiac death (VT). Management: Echo/MRI to assess RV volume.
Cross-Exam: 1. Q: Why RVH? A: RV outflow obstruction. 2. Q: Common rhythm? A: VT (scar-related). 3. Q: After repair? A: RBBB. 4. Q: What is the "Tet spell"? A: Infundibular spasm. 5. Q: Goal of surgery? A: Relieve RVOT.
4. Ebstein Anomaly
Diagnosis: Ebstein Anomaly. Pathognomonic Sign: Giant P-waves (Himalayan P-waves) and RBBB with prolonged PR. Clinical Risk: WPW (accessory pathways). Management: EPS for arrhythmia.
Cross-Exam: 1. Q: Why giant P? A: Massive RA enlargement. 2. Q: Arrhythmia association? A: WPW. 3. Q: Cardiac shape? A: Box-shaped heart on CXR. 4. Q: Valve anatomy? A: Apical displacement of tricuspid. 5. Q: Prognosis? A: Depends on RV function.
5. D-TGA (Post-Arterial Switch)
Diagnosis: Post-Jatene procedure TGA. Pathognomonic Sign: RVH, potentially abnormal Q-waves (coronary reimplantation). Clinical Risk: Coronary ostial stenosis. Management: Periodic stress testing/CCTA.
Cross-Exam: 1. Q: What is Jatene? A: Arterial switch. 2. Q: Major risk? A: Coronary ischemia. 3. Q: Can they have VT? A: Yes. 4. Q: Why abnormal Q? A: Coronary button ischemia. 5. Q: What is Mustard? A: Atrial switch.
6. Congenitally Corrected TGA (L-TGA)
Diagnosis: L-TGA. Pathognomonic Sign: Q-waves in V1 (septal inversion). Clinical Risk: Progressive complete heart block. Management: Regular Holter/Pacemaker evaluation.
Cross-Exam: 1. Q: Why Q in V1? A: Septal depolarization is reversed. 2. Q: Why AV block? A: Anomalous conduction system. 3. Q: Systemic RV? A: Yes, morphological RV supports systemic circuit. 4. Q: Can it fail? A: High risk of RV failure. 5. Q: Surgery? A: Double switch.
7. Pulmonary Stenosis (Severe)
Diagnosis: Severe PS. Pathognomonic Sign: RAD and extreme RVH with "qR" in V1. Clinical Risk: RV failure. Management: Balloon Valvuloplasty.
Cross-Exam: 1. Q: Gradient threshold? A: > 50 mmHg. 2. Q: Why qR in V1? A: Systemic-level RV pressure. 3. Q: What is Noonan syndrome? A: Genetic association. 4. Q: What if P-pulmonale? A: Severe RVH. 5. Q: Treatment? A: BPV.
8. Coarctation of Aorta
Diagnosis: Coarctation. Pathognomonic Sign: LVH criteria and strain. Clinical Risk: Aortic rupture/HTN. Management: BP management/Stent.
Cross-Exam: 1. Q: Why LVH? A: Pressure overload. 2. Q: Associated defect? A: Bicuspid aortic valve. 3. Q: What is Turner syndrome? A: High association. 4. Q: ECG feature? A: LV strain V5-V6. 5. Q: Pulse check? A: Radio-femoral delay.
9. Pulmonary Hypertension (CHD-related)
Diagnosis: PAH. Pathognomonic Sign: RAD, RAE, and RVH with deep S in V5/V6. Clinical Risk: RV failure. Management: PVR calculation.
Cross-Exam: 1. Q: What is Eisenmenger? A: Shunt reversal. 2. Q: Why deep S? A: RV dilation. 3. Q: RAE sign? A: Tall P in II. 4. Q: Can you close the shunt? A: No. 5. Q: Drug therapy? A: PDE5-inhibitors.
10. Patent Ductus Arteriosus (PDA)
Diagnosis: PDA. Pathognomonic Sign: LVH with deep Q-waves in I, aVL, V5, V6 (volume overload). Clinical Risk: Heart failure. Management: Closure (Device/Surgery).
Cross-Exam: 1. Q: Why deep Q? A: LV volume overload. 2. Q: Continuous murmur? A: Yes. 3. Q: Pulse? A: Wide pulse pressure. 4. Q: Preterm cause? A: Lack of O2 constriction. 5. Q: Complication? A: Endarteritis.
11. Tricuspid Atresia
Diagnosis: Tricuspid Atresia. Pathognomonic Sign: LAD and LVH (RV is hypoplastic). Clinical Risk: Cyanosis/Failure. Management: Fontan pathway.
Cross-Exam: 1. Q: Axis? A: Left. 2. Q: Why LVH? A: LV handles both circuits. 3. Q: Cyanotic? A: Yes. 4. Q: Surgery stages? A: BT shunt -> Glenn -> Fontan. 5. Q: Blood flow? A: ASD dependent.
12. HLHS (Hypoplastic Left Heart Syndrome)
Diagnosis: HLHS. Pathognomonic Sign: RVH, RAE, and low voltage in limb leads. Clinical Risk: Shock. Management: Norwood procedure/PGE1.
Cross-Exam: 1. Q: Ductal dependent? A: Yes. 2. Q: Why low voltage? A: Small LV mass. 3. Q: Mortality? A: High. 4. Q: Stage 1? A: Norwood. 5. Q: What to give? A: Prostaglandin.
13. TAPVR (Obstructed)
Diagnosis: Obstructed TAPVR. Pathognomonic Sign: Severe RAD, RAE, and RVH. Clinical Risk: Pulmonary edema. Management: Emergency surgery.
Cross-Exam: 1. Q: Why severe RVH? A: Obstruction to pulmonary return. 2. Q: CXR sign? A: Snowman heart (unobstructed). 3. Q: Is it cyanotic? A: Yes. 4. Q: Surgery urgency? A: Immediate. 5. Q: Why? A: Pulmonary crisis.
14. Ebstein (WPW focus)
Diagnosis: Ebstein with WPW. Pathognomonic Sign: RBBB, prolonged PR, and Delta wave. Clinical Risk: Sudden VT/SCD. Management: Ablation.
Cross-Exam: 1. Q: Pre-excitation prevalence? A: 20%. 2. Q: Arrhythmia? A: SVT/AF. 3. Q: Why prolonged PR? A: Inter-atrial conduction delay. 4. Q: Valve anatomy? A: Tricuspid leaflet tethering. 5. Q: Why dangerous? A: Multiple pathways.
15. Total Anomalous Pulmonary Venous Connection (Unobstructed)
Diagnosis: TAPVR (Supracardiac). Pathognomonic Sign: RAE, RVH, and "rSr'" in V1. Clinical Risk: RV volume overload. Management: Surgical redirection.
Cross-Exam: 1. Q: Axis? A: Right. 2. Q: P-wave? A: Tall P (RAE). 3. Q: Cyanosis? Mild. 4. Q: What is Snowman? A: Vertical vein + SVC dilation. 5. Q: Can it cause PHTN? A: Eventually.
16. Truncus Arteriosus
Diagnosis: Truncus Arteriosus. Pathognomonic Sign: Combined LVH and RVH. Clinical Risk: PHTN. Management: Early surgical repair.
Cross-Exam: 1. Q: Why biventricular hypertrophy? A: Both ventricles pump to single outflow. 2. Q: Cyanosis? Yes. 3. Q: DiGeorge syndrome? High association. 4. Q: Surgery? Rastelli. 5. Q: Prognosis? Poor without repair.
17. Single Ventricle (Fontan)
Diagnosis: Fontan Circulation. Pathognomonic Sign: Atrial arrhythmias/flutter, RVH/LVH (morphology depends). Clinical Risk: Failing Fontan/Arrhythmia. Management: Heart-liver transplant assessment.
Cross-Exam: 1. Q: Arrhythmia focus? A: Intra-atrial reentrant tachycardia. 2. Q: Why? A: Atrial scarring. 3. Q: Drug? Amiodarone. 4. Q: Prevention? Maze procedure. 5. Q: Complication? PLE.
18. ASD (Post-Device Closure)
Diagnosis: Post-Device ASD closure. Pathognomonic Sign: Normalization of RBBB/axis, but potential new atrial arrhythmias. Clinical Risk: Device erosion/erosion. Management: Regular Echo/Holter.
Cross-Exam: 1. Q: Why arrhythmia? A: Surgical/device scar. 2. Q: Erosion? Pericardial effusion. 3. Q: Residual shunt? Echo. 4. Q: When to check? 1, 6, 12 months. 5. Q: What is the device? Amplatzer.
19. Myocarditis (CHD related/Viral)
Diagnosis: Myocarditis. Pathognomonic Sign: ST-T changes, QRS low voltage, and new AV block. Clinical Risk: Fulminant heart failure. Management: Supportive/Inotropes.
Cross-Exam: 1. Q: QRS sign? Low voltage (edema). 2. Q: Arrhythmia? Ventricular. 3. Q: Mimic? MI. 4. Q: Test? CMR/Biopsy. 5. Q: Therapy? Vasopressors.
20. Cardiomyopathy (HCM - Genetic)
Diagnosis: Hypertrophic Cardiomyopathy. Pathognomonic Sign: Deep "dagger-like" Q-waves (I, aVL, V5, V6) and giant R-waves. Clinical Risk: Sudden cardiac death. Management: ICD assessment.
Cross-Exam: 1. Q: Why dagger Q? Septal hypertrophy. 2. Q: Risk factors for SCD? Syncope, family hx. 3. Q: Drug? Beta-blocker. 4. Q: Obstruction? SAM of MV. 5. Q: What is SAM? Systolic Anterior Motion.
30 ADDITIONAL HIGH-YIELD ECGs FOR DRNB PRACTICALS
21. Wellens’ Syndrome
Diagnosis: Wellens’ Syndrome (Critical LAD stenosis). Pathognomonic Sign: Deeply inverted T-waves (Type B) or biphasic T-waves (Type A) in V2–V3. Clinical Risk: Impending anterior wall MI. Management: Urgent coronary angiography.
Cross-Exam: 1. Q: Why is it dangerous? A: Sign of proximal LAD occlusion. 2. Q: Should you stress test? A: No, contraindicated. 3. Q: Is it STEMI? A: No, usually pain-free when ECG is taken. 4. Q: Where are T-waves seen? V2-V3. 5. Q: What is the anatomy? Proximal LAD lesion.
22. de Winter’s T-waves
Diagnosis: de Winter’s Pattern. Pathognomonic Sign: ST depression at J-point with tall, peaked T-waves in precordial leads. Clinical Risk: LAD occlusion equivalent. Management: Urgent cath lab activation.
Cross-Exam: 1. Q: Why call it STEMI equivalent? A: High risk of infarct. 2. Q: Appearance? ST downsloping with hyperacute T. 3. Q: Vessel? LAD. 4. Q: How common? Rare but critical. 5. Q: Treatment? Same as STEMI.
23. Pre-excitation (Mahaim fiber)
Diagnosis: Mahaim fiber pre-excitation. Pathognomonic Sign: RBBB pattern with delta wave. Clinical Risk: Tachycardia (antidromic). Management: EPS and ablation.
Cross-Exam: 1. Q: Difference from WPW? A: Mahaim conducts slowly. 2. Q: Rhythm? Antidromic tachycardia. 3. Q: Location? Right side. 4. Q: PR interval? Often normal. 5. Q: Treatment? Ablation.
24. ARVC (Arrhythmogenic RV Cardiomyopathy)
Diagnosis: ARVC. Pathognomonic Sign: Epsilon wave (notch at end of QRS) in V1–V3. Clinical Risk: Sudden cardiac death. Management: ICD placement.
Cross-Exam: 1. Q: What is Epsilon? Delayed RV depolarization. 2. Q: T-wave inversion? V1-V3. 3. Q: Criteria? Task Force criteria. 4. Q: Genetic? Desmosomal. 5. Q: Arrhythmia? VT (LBBB morphology).
25. Early Repolarization
Diagnosis: Early Repolarization (Benign). Pathognomonic Sign: J-point elevation with "fishhook" notch. Clinical Risk: Usually benign; check history. Management: Reassurance if asymptomatic.
Cross-Exam: 1. Q: Diff from Pericarditis? A: Stable, no PR depression. 2. Q: High risk? J-wave syndromes. 3. Q: Population? Young males. 4. Q: When to worry? Syncope. 5. Q: ST shape? Concave.
26. Osborn Waves (Hypothermia)
Diagnosis: Hypothermia. Pathognomonic Sign: J-wave (hump at J-point). Clinical Risk: Bradycardia, VF. Management: Active rewarming.
Cross-Exam: 1. Q: Temp? Usually < 32°C. 2. Q: Why J-wave? Ionic current difference. 3. Q: Arrhythmia? VF. 4. Q: Rewarming? Slow. 5. Q: Other causes? Hypercalcemia.
27. Ashman Phenomenon
Diagnosis: Ashman Phenomenon. Pathognomonic Sign: Wide QRS following a long-short cycle sequence. Clinical Risk: Misdiagnosed as VT. Management: Rate control for AF.
Cross-Exam: 1. Q: Why wide QRS? Aberrant conduction. 2. Q: Rhythm? AFib. 3. Q: Why long-short? Refractoriness change. 4. Q: Distinguish from VT? Morphology. 5. Q: Clinical significance? Benign.
28. Junctional Escape
Diagnosis: Junctional Escape Rhythm. Pathognomonic Sign: Narrow QRS, rate 40–60, absent/retrograde P. Clinical Risk: High-degree AV block. Management: Identify cause (e.g., BB overdose).
Cross-Exam: 1. Q: Rate? 40-60. 2. Q: Why narrow QRS? Supra-Hisian. 3. Q: P-wave? Inverted. 4. Q: Causes? Digoxin/BB. 5. Q: Treatment? Pacemaker if symptomatic.
29. Ventricular Tachycardia (Monomorphic)
Diagnosis: Monomorphic VT. Pathognomonic Sign: Wide QRS, regular, AV dissociation, fusion beats. Clinical Risk: Sudden death. Management: Cardioversion/Amiodarone/ICD.
Cross-Exam: 1. Q: Brugada criteria? Used to diff from SVT+BBB. 2. Q: Capture beat? Evidence of AV dissociation. 3. Q: Hemodynamic stable? Give Amiodarone. 4. Q: Unstable? DC Shock. 5. Q: Common substrate? Prior MI.
30. Torsades de Pointes
Diagnosis: Torsades de Pointes. Pathognomonic Sign: Polymorphic VT with "twisting" QRS axis. Clinical Risk: VF, syncope. Management: IV Magnesium, stop QT drugs.
Cross-Exam: 1. Q: Preceding event? Long QT. 2. Q: First line? Magnesium. 3. Q: Pacing? Overdrive pacing. 4. Q: QT drugs? Antiarrhythmics. 5. Q: Electrolyte? Hypokalemia.
31. Accelerated Idioventricular Rhythm (AIVR)
Diagnosis: AIVR. Pathognomonic Sign: Wide QRS, rate 60–100 bpm. Clinical Risk: "Reperfusion arrhythmia." Management: Usually benign, observe.
Cross-Exam: 1. Q: Reperfusion sign? Yes. 2. Q: Hemodynamics? Stable. 3. Q: Suppress? Only if symptomatic. 4. Q: Rate? 60-100. 5. Q: Why not treat? Protective.
32. Trifascicular Block
Diagnosis: Trifascicular Block. Pathognomonic Sign: RBBB + LAFB + 1st Degree AV block. Clinical Risk: Progression to CHB. Management: Electrophysiology study/PPM.
Cross-Exam: 1. Q: Which is the delay? AV node. 2. Q: Risk? High risk of CHB. 3. Q: EPS? If syncope. 4. Q: Management? Pacemaker. 5. Q: Difference from Bifascicular? PR prolongation.
33. Left Ventricular Strain
Diagnosis: LV Strain. Pathognomonic Sign: ST depression/T-wave inversion in lateral leads. Clinical Risk: Secondary to LVH. Management: Assess for HTN/AS.
Cross-Exam: 1. Q: Diff from MI? Concave shape. 2. Q: Vessel? None (subendocardial). 3. Q: Cause? LVH. 4. Q: Prognosis? Depends on LV mass. 5. Q: Echo? Shows LVH.
34. Right Atrial Enlargement (P-pulmonale)
Diagnosis: P-pulmonale. Pathognomonic Sign: Tall, peaked P-waves (>2.5mm) in lead II. Clinical Risk: Pulmonary pathology. Management: Echo.
Cross-Exam: 1. Q: Causes? COPD, PS. 2. Q: Lead II? Tallest P. 3. Q: Sensitivity? Poor. 4. Q: What is P-mitrale? Broad/notched P. 5. Q: Clinical? JVP rise.
35. Left Atrial Enlargement (P-mitrale)
Diagnosis: P-mitrale. Pathognomonic Sign: Broad, notched P-wave (>0.12s) in lead II. Clinical Risk: MS/MR, AFib. Management: Echo.
Cross-Exam: 1. Q: Pathophysiology? LA enlargement. 2. Q: Disease? MS. 3. Q: Rhythm risk? AFib. 4. Q: Lead V1? Biphasic P. 5. Q: Sign? Double contour on CXR.
36. Hypercalcemia
Diagnosis: Hypercalcemia. Pathognomonic Sign: Shortened QT interval. Clinical Risk: Arrhythmia. Management: Fluids/Bisphosphonates.
Cross-Exam: 1. Q: Why short QT? Short ST. 2. Q: Rhythm? Bradycardia. 3. Q: Cause? Hyperparathyroidism. 4. Q: Calcium effect? Shortens repolarization. 5. Q: First line? Rehydration.
37. Hypocalcemia
Diagnosis: Hypocalcemia. Pathognomonic Sign: Prolonged QT (ST segment lengthening). Clinical Risk: Torsades. Management: IV Calcium.
Cross-Exam: 1. Q: Why long QT? Long ST. 2. Q: Arrhythmia? Torsades. 3. Q: Chvostek sign? Facial nerve tap. 4. Q: First step? IV Ca gluconate. 5. Q: Why check Mg? HypoMg causes HypoCa.
38. Pericardial Tamponade (Electrical Alternans)
Diagnosis: Electrical Alternans. Pathognomonic Sign: Alternating QRS amplitude beat-to-beat. Clinical Risk: Tamponade. Management: Pericardiocentesis.
Cross-Exam: 1. Q: Mechanism? Heart swinging. 2. Q: Tamponade? Yes. 3. Q: Pulses? Paradoxus. 4. Q: First test? Echo. 5. Q: Urgent? Yes.
39. Sick Sinus Syndrome (SSS)
Diagnosis: SSS. Pathognomonic Sign: Tachy-Brady syndrome (alternating runs of SVT and sinus pause). Clinical Risk: Syncope/stroke. Management: Pacemaker.
Cross-Exam: 1. Q: Components? Sinus pause/SVT. 2. Q: Symptom? Syncope. 3. Q: PPM? Indicated if symptomatic. 4. Q: Why stroke? AFib runs. 5. Q: Age? Elderly.
40. Ventricular Escape
Diagnosis: Idioventricular Rhythm. Pathognomonic Sign: Wide QRS, rate < 40 bpm. Clinical Risk: Severe heart block. Management: Temporary pacing.
Cross-Exam: 1. Q: Origin? Ventricle. 2. Q: Why dangerous? Unstable. 3. Q: Rate? <40. 4. Q: Difference from Junctional? QRS width. 5. Q: Therapy? Pacing.
41. Flecainide Toxicity
Diagnosis: Flecainide Toxicity. Pathognomonic Sign: Marked QRS widening (>140ms) and secondary T-wave changes. Clinical Risk: Ventricular arrhythmias (Monomorphic VT/VF). Management: Hypertonic Sodium Bicarbonate infusion.
Cross-Examination (5 Q&A):
Q: Mechanism? A: Class 1c sodium channel blocker. 2. Q: Why Bicarbonate? A: Increases extracellular Na+ to overcome block. 3. Q: Arrhythmia? Monomorphic VT. 4. Q: Sign? Massive QRS prolongation. 5. Q: Prognosis? Poor if not treated quickly.
42. Hypertrophic Cardiomyopathy (HCM)
Diagnosis: HCM. Pathognomonic Sign: Deep "dagger-like" Q-waves in leads I, aVL, V5, V6. Clinical Risk: Sudden cardiac death. Management: ICD risk stratification and Beta-blockers.
Cross-Examination (5 Q&A):
Q: Why dagger Q? A: Septal hypertrophy. 2. Q: Risk factors for SCD? A: Syncope, family history, LV wall thickness > 30mm. 3. Q: Drug? Beta-blocker. 4. Q: Obstruction? SAM of MV. 5. Q: What is SAM? Systolic Anterior Motion.
43. Acute Pulmonary Embolism (PE)
Diagnosis: Acute PE. Pathognomonic Sign: S1Q3T3 pattern, RAD, and tachycardia. Clinical Risk: Hemodynamic collapse/Right heart failure. Management: Anticoagulation/Thrombolysis.
Cross-Examination (5 Q&A):
Q: Classic pattern? A: S1Q3T3. 2. Q: Most common? A: Sinus tachycardia. 3. Q: Why RAD? A: Acute RV strain. 4. Q: T-wave inversion? V1-V4. 5. Q: High risk? Hypotension/Shock.
44. Digoxin Effect
Diagnosis: Digoxin effect (not toxicity). Pathognomonic Sign: Down-sloping ST segment ("Salvador Dali"). Clinical Risk: Benign (no toxicity). Management: None; continue monitoring.
Cross-Examination (5 Q&A):
Q: Diff from toxicity? A: Toxicity has arrhythmias. 2. Q: Mechanism? At-site binding. 3. Q: Is it clinical ischemia? No. 4. Q: Lead location? Lateral. 5. Q: Significance? Just medication effect.
45. Early Repolarization (High Risk)
Diagnosis: High-risk Early Repolarization. Pathognomonic Sign: J-point elevation in inferior/lateral leads with horizontal/downsloping ST. Clinical Risk: VF/SCD. Management: ICD if syncope occurs.
Cross-Examination (5 Q&A):
Q: What is high risk? ST slope. 2. Q: Population? Athletes/Young males. 3. Q: When to ICD? Syncope. 4. Q: Diff from MI? Stable over time. 5. Q: Underlying? Channelopathy (rare).
46. Pacemaker Rhythm (DDD)
Diagnosis: DDD Pacemaker Rhythm. Pathognomonic Sign: Pacer spikes followed by QRS; wide QRS (LBBB morphology). Clinical Risk: Pacer malfunction/lead failure. Management: Check lead integrity via interrogation.
Cross-Examination (5 Q&A):
Q: Morphology? LBBB (pacing from RV). 2. Q: "Failure to capture"? Spike but no QRS. 3. Q: "Failure to pace"? No spike. 4. Q: Oversensing? Pacer ignores beats. 5. Q: Lead placement? RV apex.
47. Long QT Type 1 (LQT1)
Diagnosis: LQT1. Pathognomonic Sign: Broad-based T-waves and prolonged QTc. Clinical Risk: SCD triggered by swimming/exercise. Management: Beta-blockers (propranolol/nadolol).
Cross-Examination (5 Q&A):
Q: Trigger? Exercise (swimming). 2. Q: Gene? KCNQ1. 3. Q: First line? Beta-blocker. 4. Q: ECG feature? Broad T-wave. 5. Q: Difference from LQT2/3? Trigger mechanism.
48. Pericardial Effusion (Alternans)
Diagnosis: Electrical Alternans. Pathognomonic Sign: Beat-to-beat variation in QRS amplitude. Clinical Risk: Tamponade. Management: Pericardiocentesis.
Cross-Examination (5 Q&A):
Q: Mechanism? Swinging heart. 2. Q: Tamponade? Yes. 3. Q: Pulses? Paradoxus. 4. Q: First test? Echo. 5. Q: Urgent? Yes.
49. Sinus Pause (Sinoatrial Exit Block)
Diagnosis: Sinus Pause. Pathognomonic Sign: Intermittent loss of P-QRS complex. Clinical Risk: Syncope (SSS). Management: If symptomatic, pacemaker.
Cross-Examination (5 Q&A):
Q: Pause length? > 2 seconds. 2. Q: Rhythm? Sinus. 3. Q: Symptom? Syncope/Dizziness. 4. Q: Causes? Fibrosis/Medications. 5. Q: When PPM? Symptomatic.
50. Ventricular Escape Rhythm
Diagnosis: Idioventricular Rhythm. Pathognomonic Sign: Wide QRS, rate < 40 bpm. Clinical Risk: Severe AV block/syncope. Management: Immediate transvenous pacing.
Cross-Examination (5 Q&A):
Q: Origin? Ventricular. 2. Q: Rate? < 40. 3. Q: QRS width? Wide. 4. Q: Treatment? Pacemaker. 5. Q: Prognosis? Poor without support.
Comments
Post a Comment
Join the academic discussion. Share your clinical insights, questions, or perspectives below.